Obstructive sleep apnea is already known to stress the heart. A new population-level study now quantifies that risk with unusual precision — and finds that the consequences extend into metabolic and mental health as well.
The study, a collaboration between Imperial College Health Partners, Imperial College Healthcare NHS Trust, and Eli Lilly and Company, was presented at the European Congress on Obesity (ECO 2026) in Istanbul. Drawing on electronic health records from 2.9 million residents of North-West London, it is one of the largest real-world analyses of sleep apnea outcomes to date.
The Core Finding
Researchers matched 20,300 adults diagnosed with obstructive sleep apnea to 97,412 comparable individuals without the condition, controlling for demographics, smoking status, obesity, comorbidity count, and prior cardiovascular events.
Within four years, 26.3% of those with OSA experienced a cardiovascular event or died from any cause, compared to 17.5% of matched controls — a 71% higher risk overall.
The finding held even after accounting for obesity, which overlaps heavily with sleep apnea. Between 40% and 70% of people with OSA are also living with obesity, and the two conditions share biological pathways involving inflammation, metabolic disruption, and sympathetic nervous system activation.
Beyond the Heart
The study also tracked new diagnoses of other conditions in participants who did not already have them at baseline. Compared to controls, people with OSA had higher rates of developing:
- Obesity: 5.6% vs. 4.0%
- Type 2 diabetes: 6.8% vs. 4.6%
- Osteoarthritis: 4.2% vs. 3.0%
- Anxiety: 5.2% vs. 3.2%
- Depression: 4.7% vs. 3.0%
These differences are notable because the study controlled for existing conditions at baseline. The elevated rates suggest that OSA may contribute to the development of these conditions rather than simply coexisting with them — though the observational design cannot prove causation.
Why Sleep Apnea Damages More Than Sleep
The biological mechanisms connecting OSA to cardiovascular and metabolic disease are well established. Each time the airway collapses during sleep, blood oxygen drops and the brain triggers a brief arousal to restore breathing. This cycle — repeated dozens or hundreds of times per night — causes:
- Surges in blood pressure and stress hormones that strain the cardiovascular system
- Chronic inflammation linked to insulin resistance and arterial damage
- Sympathetic nervous system overactivation that persists into waking hours
- Fragmented sleep that disrupts hormonal regulation of appetite, mood, and energy
The connection to anxiety and depression may reflect both the physiological stress of intermittent hypoxia and the subjective toll of chronic fatigue and impaired daytime functioning.
The Scale of the Problem
The World Sleep Society estimates that nearly one billion people worldwide have obstructive sleep apnea, with the majority undiagnosed. In many cases, patients present first with cardiovascular disease, diabetes, or depression — and the underlying sleep disorder is discovered only later, if at all.
The challenge is that sleep apnea often goes undiagnosed until its consequences have already taken root. Population-level data like this reinforces the case for earlier screening.
What This Means for Patients
This study does not introduce a new mechanism or treatment. What it provides is scale — a population-level confirmation that OSA's cardiovascular and metabolic consequences are substantial, consistent, and present even when obesity and other shared risk factors are accounted for.
For patients already diagnosed with sleep apnea, the findings reinforce the importance of consistent treatment — whether through CPAP, oral appliances, or newer alternatives. For those with risk factors like obesity or a partner who reports loud snoring, the data adds urgency to getting evaluated.
And for clinicians managing cardiovascular disease, diabetes, or mental health conditions, the study is a reminder that undiagnosed sleep apnea may be driving outcomes from behind the scenes.
